Presentation: Kate Seib

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

please check before submitting

Mobile number:

What is your role?

Subscribe to VaccineNation Newsletter?

Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

At the World Vaccine Congress 2012 in Washington we had the pleasure of welcoming Dr Kate Seib, one of the closest collaborators of Dr Rappuoli in Sienna. Dr Seib shared the team’s view on how they believe that reverse vaccinology is the key to novel antigens and talked us through the following points in her very interesting presentation:

• Using reverse vaccinology to identify novel antigens for vaccine development
• Applying genomics, immunology & engineering to rapidly assess vaccine candidates
• New applications for reverse vaccinology and their impact on vaccine R&D

RV is now poised to deliver on its early promise, with the European Medicines Agency currently reviewing the first RV-derived vaccine: Novartis’s Bexsero.

Download the full presentation here.

Presentation: Kate Seib

information we require

please check before submitting